Cargando…
MT1JP-mediated miR-24-3p/BCL2L2 axis promotes Lenvatinib resistance in hepatocellular carcinoma cells by inhibiting apoptosis
PURPOSE: Lenvatinib is a long-awaited alternative to Sorafenib for first-line targeted therapy of patients with advanced hepatocellular carcinoma (HCC). However, resistance to Lenvatinib results in tumor progression and has become a major obstacle to improving the prognosis of HCC patients. Explorin...
Autores principales: | Yu, Ting, Yu, Jiajian, Lu, Lu, Zhang, Yize, Zhou, Yadong, Zhou, Yong, Huang, Fengling, Sun, Lu, Guo, Zhixian, Hou, Guojun, Dong, Zihui, Wang, Bibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338827/ https://www.ncbi.nlm.nih.gov/pubmed/33974236 http://dx.doi.org/10.1007/s13402-021-00605-0 |
Ejemplares similares
-
MT1JP inhibits glioma progression via negative regulation of miR-24
por: Chen, Jinming, et al.
Publicado: (2020) -
Discrepancies in Antimicrobial Susceptibility between the JP2 and the Non-JP2 Genotype of Aggregatibacter actinomycetemcomitans
por: Granlund, Margareta, et al.
Publicado: (2022) -
Genomic Islands Shape the Genetic Background of Both JP2 and Non-JP2 Aggregatibacter actinomycetemcomitans
por: Kittichotirat, Weerayuth, et al.
Publicado: (2022) -
LncRNA MT1JP functions as a tumor suppressor by interacting with TIAR to modulate the p53 pathway
por: Liu, Lihui, et al.
Publicado: (2016) -
Overexpression of lncRNA MT1JP Mediates Apoptosis and Migration of Hepatocellular Carcinoma Cells by Regulating miR-24-3p
por: Shan, Qiu-Li, et al.
Publicado: (2020)